查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1807405

动物用医药品原料药製造的全球市场:市场规模·占有率·趋势，产业分析 (服务类别·合成类别·动物类别·各治疗类别·各地区)，2025年～2034年的市场预测

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, Share, Trends, & Industry Analysis Report By Service Type, By Synthesis Type, By Animal Type, By Therapeutic Category, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 125 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，预计到 2034 年，兽药活性成分製造市场规模将达到 170.8 亿美元。本报告深入分析了当前的市场动态，并分析了未来的市场成长。

兽药活性成分 (VAPI) 是用于治疗、预防或诊断动物疾病的药品中的生物活性物质。它们是实现预期治疗效果的核心成分。兽药活性成分 (VAPI) 製造是一个复杂且受到严格监管的合成或提取生物活性物质的过程。该过程涉及化学合成、发酵或从天然来源分离，然后进行广泛的纯化和严格的品质控制，以确保其特性、效力、纯度和安全性。

兽药的生产过程必须严格遵守美国食品药物管理局 (FDA) 和欧洲药品管理局 (EMA) 等机构制定的良好生产规范 (GMP) 标准。不同动物物种的生理差异，例如代谢率、消化系统和特定疾病病原体，也会影响药物的设计、合成和纯化。

动物药物製造市场：分析概论

按服务类型划分，内部服务部分将在 2024 年占 64.32% 的收入占有率，因为大型动物保健公司强烈希望保持对其生产流程的控制。

按合成类型划分，基于化学原料药的部分将在 2024 年占 72.34% 的收入占有率。化学合成具有可扩展性、成本效益和一致性，使其成为生产牲畜和伴侣动物常见疾病的药物的首选方法。

按动物类型划分，由于肉类、乳製品和家禽产品需求的不断增长，生产性动物细分市场在2024年占了61.32%的收入占有率。

按治疗类别划分，由于伴侣动物和牲畜持续面临细菌和病毒性疾病的威胁，抗感染药物细分市场在2024年占了最大的收入占有率。

北美动物药物活性成分製造市场在2024年占了最大的收入占有率。这种主导地位归因于伴侣动物拥有率的不断提高。

预计未来几年亚太地区动物药物产业将以最快的速度成长。这得益于中产阶级人口的成长、宠物拥有量的增加以及高端兽医护理支出的增加。

全球主要公司包括 Alivira Animal Health Limited、AMGIS Lifescience Ltd.、Bimeda Inc.、ChemPro Pharma Private Limited、Excel Industries Limited、FIS-Fabbrica Italiana Sintetici S.p.A.、Grupo Indukern S.L.、Huvepharma AD、Hraneng Pharmam. B.V.、SUANFARMA S.A.、Zoetis Inc. 等。

目录

第1章 简介

第2章 摘要整理

第3章 分析方法

第4章 全球动物用医药品原料药製造市场洞察

  • 市场概述
  • 动物用医药品原料药製造的市场动态
    • 促进因素和机会
      • 动物保健支出增加
      • 设施扩建投资增加
    • 限制与课题
      • 严格监管
  • 大环境分析
  • 动物用医药品原料药製造市场趋势
  • 价值链分析

第5章 全球动物用医药品原料药製造市场:服务类别

  • 主要的分析结果
  • 简介
  • 公司内部生产
  • 外包生产

第6章 全球动物用医药品原料药製造市场:合成类别

  • 主要的分析结果
  • 简介
  • 化学为基础的API
  • 生物学的API
  • HPAPI

第7章 全球动物用医药品原料药製造市场:动物类别

  • 主要的分析结果
  • 简介
  • 生产动物
  • 宠物

第8章 全球动物用医药品原料药製造市场:各治疗类别

  • 主要的分析结果
  • 简介
  • 抗寄生虫药
  • 抗感染疾病药
  • NSAID
  • 其他

第9章 全球动物用医药品原料药製造市场:各地区

  • 主要的分析结果
  • 简介
    • 动物用医药品原料药製造市场分析:各地区 (2020～2034年)
  • 北美
    • 北美:服务类别(2020～2034年)
    • 北美:合成类别(2020～2034年)
    • 北美:动物类别(2020～2034年)
    • 北美:各治疗类别(2020～2034年)
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:服务类别(2020～2034年)
    • 欧洲:合成类别(2020～2034年)
    • 欧洲:动物类别(2020～2034年)
    • 欧洲:各治疗类别(2020～2034年)
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:服务类别(2020～2034年)
    • 亚太地区:合成类别(2020～2034年)
    • 亚太地区:动物类别(2020～2034年)
    • 亚太地区:各治疗类别(2020～2034年)
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:服务类别(2020～2034年)
    • 中东·非洲:合成类别(2020～2034年)
    • 中东·非洲:动物类别(2020～2034年)
    • 中东·非洲:各治疗类别(2020～2034年)
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:服务类别(2020～2034年)
    • 南美:合成类别(2020～2034年)
    • 南美:动物类别(2020～2034年)
    • 南美:各治疗类别(2020～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第10章 竞争情形

  • 事业扩大·企业收购的分析
    • 事业扩大
    • 企业收购
  • 联盟/合作/协定/公开

第11章 企业简介

  • Alivira Animal Health Limited
  • AMGIS Lifescience Ltd.
  • Bimeda Inc.
  • Chempro Pharma Private Limited
  • Excel Industries Limited
  • FIS-Fabbrica Italiana Sintetici S.p.A.
  • Grupo Indukern S.L.
  • Huateng Pharma
  • Huvepharma AD
  • Menadiona S.L.
  • NGL Fine-Chem Ltd.
  • Ofichem Group B.V.
  • SUANFARMA S.A
  • Zoetis Inc.
Product Code: PM4540

The veterinary active pharmaceutical ingredients manufacturing market size is expected to reach USD 17.08 billion by 2034, according to a new study by Polaris Market Research. The report "Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, Size, Trends, Industry Analysis Report: By Service Type (In-House and Contract Outsourcing), By Synthesis Type, By Animal Type, By Therapeutic Category, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Veterinary active pharmaceutical ingredients (VAPIs) are the biologically active substances in medicinal products used to treat, prevent, or diagnose diseases in animals. They are the core components responsible for the intended therapeutic effect. Veterinary active pharmaceutical ingredients (VAPIs) manufacturing is the complex, highly regulated process of synthesizing or extracting biologically active substances. This involves chemical synthesis, fermentation, or isolation from natural sources, followed by extensive purification and stringent quality control to ensure identity, potency, purity, and safety.

The manufacturing process of veterinary active pharmaceutical ingredients must adhere to rigorous good manufacturing practice (GMP) standards set by authorities like the FDA and EMA. The physiological differences between species, such as metabolic rates, digestive systems, and specific disease pathogens, also influence the design, synthesis, and purification of the API.

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report Highlights

In terms of service type, the in-house segment accounted for 64.32% of revenue share in 2024 due to the strong preference of major veterinary pharmaceutical companies to maintain control over their production processes.

Based on synthesis type, the chemical-based API segment held 72.34% of the revenue share in 2024. Chemical synthesis provided scalability, cost efficiency, and consistency, making it the preferred choice for manufacturing drugs that target common conditions in both livestock and companion animals.

In terms of animal type, the production animals segment accounted for 61.32% of revenue share in 2024 due to rising demand for meat, dairy, and poultry products.

Based on therapeutic category, the anti-infectives segment held the largest revenue share in 2024 due to the persistent threat of bacterial and viral diseases in companion and farm animals.

North America veterinary active pharmaceutical ingredients manufacturing market accounted for the largest revenue share in 2024. This dominance is attributed to rising companion animal ownership rates.

The industry in the Asia Pacific is projected to grow at the fastest pace in the coming years, owing to a growing middle-class population, increasing pet ownership, and rising spending on premium veterinary care.

A few global key market players include Alivira Animal Health Limited; AMGIS Lifescience Ltd.; Bimeda Inc.; Chempro Pharma Private Limited; Excel Industries Limited; FIS - Fabbrica Italiana Sintetici S.p.A.; Grupo Indukern S.L.; Huvepharma AD; Huateng Pharma; Menadiona S.L.; NGL Fine-Chem Ltd.; Ofichem Group B.V.; SUANFARMA S.A.; and Zoetis Inc.

Polaris Market Research has segmented the market report on the basis of service type, synthesis type, animal type, therapeutic category, and region:

By Service Type Outlook (Revenue, USD Billion, 2020-2034)

In House

Contract Outsourcing

Contract Development

Preclinical Development

Clinical Development

Contract Manufacturing

By Synthesis Type Mode Outlook (Revenue, USD Billion, 2020-2034)

Chemical-based API

Biological API

HPAPI

By Animal Type Outlook (Revenue, USD Billion, 2020-2034)

Production Animals

Companion Animals

By Therapeutic Category Outlook (Revenue, USD Billion, 2020-2034)

Antiparasitics

Anti-infectives

NSAIDs

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Insights

  • 4.1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Market Snapshot
  • 4.2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Expenditure on Animal Health
      • 4.2.1.2. Increasing Investment in Facility Expansion
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Stringent Regulation
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Trends
  • 4.6. Value Chain Analysis

5. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • 5.3. In House
    • 5.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by In House, by Region, 2020-2034 (USD Billion)
  • 5.4. Contract Outsourcing
    • 5.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Outsourcing, by Region, 2020-2034 (USD Billion)
    • 5.4.2. Contract Development
      • 5.4.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Development, by Region, 2020-2034 (USD Billion)
      • 5.4.2.2. Preclinical Development
      • 5.4.2.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Preclinical Development, by Region, 2020-2034 (USD Billion)
      • 5.4.2.3. Clinical Development
      • 5.4.2.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Clinical Development, by Region, 2020-2034 (USD Billion)
    • 5.4.3. Contract Manufacturing
      • 5.4.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Manufacturing, by Region, 2020-2034 (USD Billion)

6. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • 6.3. Chemical-based API
    • 6.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Chemical-based API, by Region, 2020-2034 (USD Billion)
  • 6.4. Biological API
    • 6.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Biological API, by Region, 2020-2034 (USD Billion)
  • 6.5. HPAPI
    • 6.5.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by HPAPI, by Region, 2020-2034 (USD Billion)

7. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • 7.3. Production Animals
    • 7.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Production Animals, by Region, 2020-2034 (USD Billion)
  • 7.4. Companion Animals
    • 7.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Companion Animals, by Region, 2020-2034 (USD Billion)

8. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • 8.3. Antiparasitics
    • 8.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Antiparasitics, by Region, 2020-2034 (USD Billion)
  • 8.4. Anti-infectives
    • 8.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Anti-infectives, by Region, 2020-2034 (USD Billion)
  • 8.5. NSAIDs
    • 8.5.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by NSAIDs, by Region, 2020-2034 (USD Billion)
  • 8.6. Others
    • 8.6.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - North America
    • 9.3.1. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
    • 9.3.2. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
    • 9.3.3. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
    • 9.3.4. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.3.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - US
      • 9.3.5.1. US: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.3.5.2. US: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.3.5.3. US: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.3.5.4. US: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.3.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Canada
      • 9.3.6.1. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • 9.4. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Europe
    • 9.4.1. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
    • 9.4.2. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
    • 9.4.3. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
    • 9.4.4. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.4.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - UK
      • 9.4.5.1. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.4.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - France
      • 9.4.6.1. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.4.6.2. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.4.6.3. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.4.6.4. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.4.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Germany
      • 9.4.7.1. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.4.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Italy
      • 9.4.8.1. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.4.9. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Spain
      • 9.4.9.1. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.4.10. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Netherlands
      • 9.4.10.1. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.4.11. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Russia
      • 9.4.11.1. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.4.12. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • 9.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Asia Pacific
    • 9.5.1. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.5.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - China
      • 9.5.5.1. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.5.5.2. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.5.5.3. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.5.5.4. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.5.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - India
      • 9.5.6.1. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.5.6.2. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.5.6.3. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.5.6.4. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.5.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Malaysia
      • 9.5.7.1. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.5.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Japan
      • 9.5.8.1. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.5.9. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Indonesia
      • 9.5.9.1. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.5.10. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - South Korea
      • 9.5.10.1. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.5.11. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Australia
      • 9.5.11.1. Australia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.5.12. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • 9.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.6.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.6.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - UAE
      • 9.6.6.1. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.6.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Israel
      • 9.6.7.1. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.6.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - South Africa
      • 9.6.8.1. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.6.9. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • 9.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Latin America
    • 9.7.1. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.7.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Mexico
      • 9.7.5.1. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.7.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Brazil
      • 9.7.6.1. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.7.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Argentina
      • 9.7.7.1. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.7.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Alivira Animal Health Limited
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. AMGIS Lifescience Ltd.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Bimeda Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Chempro Pharma Private Limited
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Excel Industries Limited
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. FIS - Fabbrica Italiana Sintetici S.p.A.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Grupo Indukern S.L.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Huateng Pharma
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Huvepharma AD
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Menadiona S.L.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. NGL Fine-Chem Ltd.
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Ofichem Group B.V.
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. SUANFARMA S.A
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Zoetis Inc.
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development

List of Tables:

  • Table 1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 4 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 5 North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 6 North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 7 North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 8 North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 9 U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 10 U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 11 U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 12 U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 13 Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 14 Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 15 Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 16 Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 17 Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 18 Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 19 Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 20 Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 21 UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 22 UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 23 UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 24 UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 25 France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 26 France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 27 France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 28 France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 29 Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 30 Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 31 Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 32 Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 33 Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 34 Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 35 Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 36 Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 37 Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 38 Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 39 Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 40 Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 41 Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 42 Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 43 Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 44 Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 45 Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 46 Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 47 Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 48 Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 49 Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 50 Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 51 Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 52 Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 53 Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 54 Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 55 Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 56 Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 57 China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 58 China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 59 China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 60 China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 61 India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 62 India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 63 India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 64 India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 65 Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 66 Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 67 Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 68 Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 69 Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 70 Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 71 Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 72 Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 73 Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 74 Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 75 Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 76 Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 77 South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 78 South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 79 South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 80 South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 81 Australia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 82 Australia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 83 Australia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 84 Australia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 89 Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 90 Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 91 Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 92 Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 93 Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 94 Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 95 Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 96 Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 97 UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 98 UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 99 UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 100 UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 101 Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 102 Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 103 Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 104 Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 105 South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 106 South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 107 South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 108 South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 113 Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 114 Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 115 Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 116 Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 117 Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 118 Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 119 Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 120 Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 121 Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 122 Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 123 Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 124 Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 125 Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 126 Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 127 Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 128 Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • Table 129 Rest of Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • Table 130 Rest of Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • Table 131 Rest of Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • Table 132 Rest of Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Service Type
  • Figure 7. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Synthesis Type
  • Figure 9. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Animal Type
  • Figure 11. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Therapeutic Category
  • Figure 13. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2024 & 2034 (USD Billion)